Goldman Sachs
TMDX icon

Goldman Sachs’s Transmedics TMDX Stock Holding History

Goldman Sachs’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,000
Closed -$6.73M – 6819
2025
Q3 		$6.73M Buy
+60,000
New +$7.02M ﹤0.01% 3369

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Goldman Sachs's TMDX Position: Q1 2026 in Review

Goldman Sachs reduced its Transmedics (TMDX) stake by 10% in Q1 2026, selling an estimated $13M and leaving 866,282 shares worth $86.1M. The position accounts for 0.01% of the portfolio, ranked #1133.

Goldman Sachs first reported a position in TMDX in Q1 2020 and has held it in 25 quarters since. The position peaked at $118M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Goldman Sachs held 866,282 shares of Transmedics worth $86.1M as of Q1 2026.
  • Goldman Sachs sold 99,649 Transmedics shares in Q1 2026, an estimated $13M.
  • Transmedics made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1133 holding.
  • Goldman Sachs first reported a position in Transmedics in Q1 2020 and has held it in 25 quarters since.
  • Goldman Sachs's Transmedics position peaked at $118M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.